- Home
- WHLR vs BDRX Comparison
WHLR vs BDRX Comparison
Compare WHLR & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHLR | BDRX |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.8M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | WHLR | BDRX |
|---|---|---|
| Price | $2.05 | $1.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 517.1K |
| Earning Date | 03-03-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 184.08 | N/A |
| Revenue | ★ $101,834,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.01 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.17 | $1.22 |
| 52 Week High | $5,029.50 | $92.00 |
Technical Indicators
Market Signals| Indicator | WHLR | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.37 | 28.35 |
| Support Level | $2.28 | $1.22 |
| Resistance Level | $3.00 | $1.38 |
| Average True Range (ATR) | 0.61 | 0.14 |
| MACD | -0.31 | 0.01 |
| Stochastic Oscillator | 3.56 | 0.93 |
Price Performance
Historical ComparisonAbout WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.